EYPT(EyePoint, Inc.) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $36.94M | $41.40M | $46.02M | $43.27M | $31.37M |
| 毛利润 | — | — | — | — | — |
| 营业利润 | −$55.28M | −$99.64M | −$75.07M | −$145.85M | −$243.43M |
| 净利润 | −$58.42M | −$102.25M | −$70.80M | −$130.87M | −$231.96M |
| 经营现金流 | −$50.10M | −$65.00M | $1.88M | −$126.23M | −$240.11M |
| 自由现金流 | −$50.25M | −$67.16M | −$1.61M | −$130.28M | −$243.39M |
| 摊薄每股收益 | $-2.03 | $-2.74 | $-1.82 | $-2320.00 | $-3170.00 |